Recent advances in clinical practice challenges and opportunities in the management of obesity

被引:71
作者
Acosta, Andres [1 ]
Abu Dayyeh, Barham K [1 ]
Port, John D [2 ]
Camilleri, Michael [1 ]
机构
[1] Mayo Clin, CENTER, Div Gastroenterol & Hepatol, Coll Med, Rochester, MN USA
[2] Mayo Clin, Div Neuroradiol, Dept Radiol, Coll Med, Rochester, MN USA
基金
美国国家卫生研究院;
关键词
GLUCAGON-LIKE PEPTIDE-1; Y GASTRIC BYPASS; DUODENAL-JEJUNAL BYPASS; RANDOMIZED-CONTROLLED-TRIAL; TYPE-2; DIABETES-MELLITUS; FOOD-INTAKE; BARIATRIC SURGERY; SLEEVE GASTRECTOMY; WEIGHT-LOSS; GLUCOSE-HOMEOSTASIS;
D O I
10.1136/gutjnl-2013-306235
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Despite advances in understanding the roles of adiposity, food intake, GI and adipocyte-related hormones, inflammatory mediators, the gut-brain axis and the hypothalamic nervous system in the pathophysiology of obesity, the effects of different therapeutic interventions on those pathophysiological mechanisms are controversial. There are still no low-cost, safe, effective treatments for obesity and its complications. Currently, bariatric surgical approaches targeting the GI tract are more effective than non-surgical approaches in inducing weight reduction and resolving obesity-related comorbidities. However, current guidelines emphasise non-surgical approaches through lifestyle modification and medications to achieve slow weight loss, which is not usually sustained and may be associated with medication-related side effects. This review analyses current central, peripheral or hormonal targets to treat obesity and addresses challenges and opportunities to develop novel approaches for obesity.
引用
收藏
页码:687 / +
页数:2
相关论文
共 115 条
  • [1] Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity
    Abu Dayyeh, Barham K.
    Rajan, Elizabeth
    Gostout, Christopher J.
    [J]. GASTROINTESTINAL ENDOSCOPY, 2013, 78 (03) : 530 - 535
  • [2] Abu Dayyeh Barham K, 2011, Therap Adv Gastroenterol, V4, P433, DOI 10.1177/1756283X11398737
  • [3] EFFECTS OF PEPTIDE-YY AND NEUROPEPTIDE-Y ON GASTRIC-EMPTYING IN MAN
    ALLEN, JM
    FITZPATRICK, ML
    YEATS, JC
    DARCY, K
    ADRIAN, TE
    BLOOM, SR
    [J]. DIGESTION, 1984, 30 (04) : 255 - 262
  • [4] Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
    Allison, David B.
    Gadde, Kishore M.
    Garvey, William Timothy
    Peterson, Craig A.
    Schwiers, Michael L.
    Najarian, Thomas
    Tam, Peter Y.
    Troupin, Barbara
    Day, Wesley W.
    [J]. OBESITY, 2012, 20 (02) : 330 - 342
  • [5] Anderson JW, 2001, AM J CLIN NUTR, V74, P579
  • [6] AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training
    Aponte, Yexica
    Atasoy, Deniz
    Sternson, Scott M.
    [J]. NATURE NEUROSCIENCE, 2011, 14 (03) : 351 - 355
  • [7] The importance of the gut microbiota after bariatric surgery
    Aron-Wisnewsky, Judith
    Dore, Joel
    Clement, Karine
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (10) : 590 - 598
  • [8] Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
    Astrup, Arne
    Rossner, Stephan
    Van Gaal, Luc
    Rissanen, Aila
    Niskanen, Leo
    Al Hakim, Mazin
    Madsen, Jesper
    Rasmussen, Mads F.
    Lean, Michael E. J.
    [J]. LANCET, 2009, 374 (9701) : 1606 - 1616
  • [9] Central melanocortin receptor agonist reduces spontaneous and scheduled meal size but does not augment duodenal preload-induced feeding inhibition
    Azzara, AV
    Sokolnicki, JP
    Schwartz, GJ
    [J]. PHYSIOLOGY & BEHAVIOR, 2002, 77 (2-3) : 411 - 416
  • [10] The gut microbiota as an environmental factor that regulates fat storage
    Bäckhed, F
    Ding, H
    Wang, T
    Hooper, LV
    Koh, GY
    Nagy, A
    Semenkovich, CF
    Gordon, JI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (44) : 15718 - 15723